Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal triamcinolone acetonide for non-arteritic anterior ischemic optic neuropathy
ACTRN12612000344897Phase 3Not yet recruiting
- Sponsor
- Khon Kaen University
- Start
- Apr 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of triamcinolone acetonide in non-arteritic anterior ischemic optic neuropathy (NAION) (2 arms), sponsored by Khon Kaen University. Primary endpoints: Best corrected visual acuity and Visual field mean deviation. Planned start Apr 2012; status: not yet recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
non-arteritic anterior ischemic optic neuropathy (NAION)
Beyond the preview
Go deeper on ACTRN12612000344897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000344897.